✦ LIBER ✦
Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre phase 2 clinical trial
✍ Scribed by Owen A. O’Connor; Craig Moskowitz; Carol Portlock; Paul Hamlin; David Straus; Otilia Dumitrescu; Debra Sarasohn; Mithat Gonen; John Butos; Ellen Neylon; Rachel Hamelers; Barbara Mac-Gregor Cortelli; Susan Blumel; Andrew D. Zelenetz; Leo Gordon; John J. Wright; Julie Vose; Brenda Cooper; Jane Winter
- Book ID
- 108676075
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 114 KB
- Volume
- 145
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.